SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Polaryx Therapeutics names Will Charlton chief medical officer

Polaryx Therapeutics appointed Will Charlton, M.D., M.A.S. as chief medical officer to lead clinical execution for PLX-200 and the SOTERIA Phase 2 trial.

PLYX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories